Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 5
2006 6
2007 6
2008 8
2009 10
2010 8
2011 9
2012 4
2013 6
2014 9
2015 10
2016 6
2017 7
2018 12
2019 9
2020 22
2021 9
2022 8
2023 12
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
The intestinal barrier in disorders of the central nervous system.
Pellegrini C, Fornai M, D'Antongiovanni V, Antonioli L, Bernardini N, Derkinderen P. Pellegrini C, et al. Among authors: fornai m. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):66-80. doi: 10.1016/S2468-1253(22)00241-2. Epub 2022 Nov 2. Lancet Gastroenterol Hepatol. 2023. PMID: 36334596 Review.
Adenosine signaling as target in cardiovascular pharmacology.
Antonioli L, Fornai M, Pellegrini C, Pacher P, Haskó G. Antonioli L, et al. Among authors: fornai m. Curr Opin Pharmacol. 2023 Aug;71:102393. doi: 10.1016/j.coph.2023.102393. Epub 2023 Jul 12. Curr Opin Pharmacol. 2023. PMID: 37450948 Review.
P2X4 receptors, immunity, and sepsis.
Antonioli L, Blandizzi C, Fornai M, Pacher P, Lee HT, Haskó G. Antonioli L, et al. Among authors: fornai m. Curr Opin Pharmacol. 2019 Aug;47:65-74. doi: 10.1016/j.coph.2019.02.011. Epub 2019 Mar 25. Curr Opin Pharmacol. 2019. PMID: 30921560 Free PMC article. Review.
Editorial: IBD Management-Novel Targets and Therapeutic Perspectives.
Antonioli L, Fornai M, Romano B, Pellegrini C, Blandizzi C. Antonioli L, et al. Among authors: fornai m. Front Pharmacol. 2020 Apr 21;11:448. doi: 10.3389/fphar.2020.00448. eCollection 2020. Front Pharmacol. 2020. PMID: 32372955 Free PMC article. No abstract available.
Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels.
Mengozzi A, Costantino S, Paneni F, Duranti E, Nannipieri M, Mancini R, Lai M, La Rocca V, Puxeddu I, Antonioli L, Fornai M, Ghionzoli M, Georgiopoulos G, Ippolito C, Bernardini N, Ruschitzka F, Pugliese NR, Taddei S, Virdis A, Masi S. Mengozzi A, et al. Among authors: fornai m. Circ Res. 2022 Sep 2;131(6):476-491. doi: 10.1161/CIRCRESAHA.122.320888. Epub 2022 Aug 15. Circ Res. 2022. PMID: 35968712 Free PMC article.
Adenosine Signaling in the Tumor Microenvironment.
Antonioli L, Fornai M, Pellegrini C, D'Antongiovanni V, Turiello R, Morello S, Haskó G, Blandizzi C. Antonioli L, et al. Among authors: fornai m. Adv Exp Med Biol. 2021;1270:145-167. doi: 10.1007/978-3-030-47189-7_9. Adv Exp Med Biol. 2021. PMID: 33123998
Adenosine pathway and cancer: where do we go from here?
Antonioli L, Haskó G, Fornai M, Colucci R, Blandizzi C. Antonioli L, et al. Among authors: fornai m. Expert Opin Ther Targets. 2014 Sep;18(9):973-7. doi: 10.1517/14728222.2014.925883. Epub 2014 Jun 24. Expert Opin Ther Targets. 2014. PMID: 24958495
Risankizumab for the treatment of moderate to severe psoriasis.
Chiricozzi A, Antonioli L, Panduri S, Fornai M, Romanelli M, Blandizzi C. Chiricozzi A, et al. Among authors: fornai m. Expert Opin Biol Ther. 2019 Jan;19(1):1-8. doi: 10.1080/14712598.2019.1551354. Epub 2018 Nov 27. Expert Opin Biol Ther. 2019. PMID: 30462554 Review.
144 results